Previous Close | 13.83 |
Open | 13.85 |
Bid | 13.74 x 100 |
Ask | 16.83 x 200 |
Day's Range | 13.14 - 14.13 |
52 Week Range | 3.50 - 15.92 |
Volume | |
Avg. Volume | 1,673,252 |
Market Cap | 2.097B |
Beta (5Y Monthly) | -1.11 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.57 |
Earnings Date | Nov 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 19.80 |
CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Tuesday, November 12, 2024, to review the company’s third quarter 2024 financial results and provide business updates. The webcast and conference call may be accessed by visiting “Investor Events” on the investors section
Key Insights Significantly high institutional ownership implies Wave Life Sciences' stock price is sensitive to their...